Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
16.12 USD | +4.37% | -5.87% | -11.53% |
May. 09 | UBS Adjusts Price Target on REGENXBIO to $39 From $43, Maintains Buy Rating | MT |
May. 08 | Transcript : REGENXBIO Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.53% | 761M | |
+4.93% | 109B | |
+11.62% | 105B | |
+0.49% | 22.25B | |
-11.77% | 22.09B | |
-7.82% | 18.68B | |
-38.36% | 17.58B | |
-9.32% | 16.85B | |
+4.57% | 13.76B | |
+37.22% | 12.46B |
- Stock Market
- Equities
- RGNX Stock
- News REGENXBIO Inc.
- Insider Trends: REGENXBIO Sees 90 Days of Insider Buying Trend Scaling Back with Share Sale